Cisco Systems (NASDAQ:CSCO) has Stabilized their Balance Sheet and can Focus on the Future

The Balance Sheet is a crucial point of review for investors, because it gives insight for the flexibility and structural integrity of an organization. That is why we are going to assess Cisco Systems, Inc. (NASDAQ:CSCO) financial health, and see if they are running effective operations.

Check out our latest analysis for Cisco Systems

Advertisement

What Is Cisco Systems's Debt?

As you can see below, Cisco Systems had US$11.5b of debt at May 2021, down from US$16.1b a year prior. But it also has US$23.6b in cash to offset that, meaning it has US$12.0b net cash.

debt-equity-history-analysis
NasdaqGS:CSCO Debt to Equity History August 11th 2021

A Look At Cisco Systems' Liabilities

Zooming in on the latest balance sheet data, we can see that Cisco Systems had liabilities of US$24.3b due within 12 months and liabilities of US$29.4b due beyond that. On the other hand, it had cash of US$23.6b and US$9.34b worth of receivables due within a year. So, its liabilities total US$20.8b more than the combination of its cash and short-term receivables. Offsetting this are Cisco's long term assets, amounting to US$56.8b.

A complete picture can be seen in the chart below:

csco-asset-structure
NasdaqGS:CSCO Assets vs Liabilities

Of course, Cisco Systems has a large market capitalization of US$234.4b, so these liabilities are probably manageable.

Despite its noteworthy liabilities, Cisco Systems boasts net cash, so it's fair to say it does not have a heavy debt load!

But the other side of the story is that Cisco Systems saw its EBIT decline by 6.3% over the last year. That sort of decline, if sustained, will obviously make debt harder to handle.

The balance sheet is clearly the area to focus on when you are analyzing debt. But ultimately, the future profitability of the business will decide if Cisco Systems can strengthen its balance sheet over time.

So if you're focused on the future, you can check out this free report showing analyst profit forecasts.

Finally, a business needs free cash flow to pay off debt. The difference between profits and free cash flow is that the first is in the books, and the second is in the bank. Investors should mostly be concerned with cash, because accountants have a lot of freedom to dance around profits.

Over the last three years, Cisco Systems actually produced more free cash flow than EBIT. There's nothing better than incoming cash when it comes to staying in your lenders' good graces. Now, let's see how Cisco is handling its cash flows:

csco-cash-flows
NasdaqGS:CSCO Cash Flows

It seems that in the previous period, the largest cash outflows were, from financing - which mostly consist of debt repayments. That is why, at the beginning of our analysis, we say the debt balance slowly go down for Cisco. Cash from operating activities is quite constant, which indicates that the business has not improved both with regard to growth or efficiency of operations. The business is also returning cash to shareholders via their dividend, which currently has a 2.66% yield.

Summing up

While it is always sensible to look at a company's total liabilities, it is very reassuring that Cisco Systems has US$12.0b in net cash. 

It impressed us with free cash flow of US$14b, being 105% of its EBIT.

The company is stabilizing its debt balance and has become more secure and stable. They can look towards the future and work on providing growth or maximizing value for shareholders. Overall, it looks like they have a healthy balance sheet.

So is Cisco Systems's debt a risk? It doesn't seem so to us. Of course, we wouldn't say no to the extra confidence that we'd gain if we knew that Cisco Systems insiders have been buying shares: if you're on the same wavelength, you can find out if insiders are buying by clicking this link.

When all is said and done, sometimes its easier to focus on companies that don't even need debt. Readers can access a list of growth stocks with zero net debt 100% free, right now.

New: AI Stock Screener & Alerts

Our new AI Stock Screener scans the market every day to uncover opportunities.

• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies

Or build your own from over 50 metrics.

Explore Now for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

Simply Wall St analyst Goran Damchevski and Simply Wall St have no position in any of the companies mentioned. This article is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.

Goran Damchevski

Goran Damchevski

Goran is an Equity Analyst and Writer at Simply Wall St with over 5 years of experience in financial analysis and company research. Goran previously worked in a seed-stage startup as a capital markets research analyst and product lead and developed a financial data platform for equity investors. 

About NasdaqGS:CSCO

Cisco Systems

Designs, develops, and sells technologies that help to power, secure, and draw insights from the internet in the Americas, Europe, the Middle East, Africa, the Asia Pacific, Japan, and China.

Solid track record established dividend payer.

Advertisement

Weekly Picks

LO
Lou_Basenese
OPTH logo
Lou_Basenese on Optimi Health ·

The Only Psychedelic Company Already Selling MDMA and Psilocybin to Real Patients, Yet Priced Like It Doesn’t Exist

Fair Value:US$1155.3% undervalued
50 users have followed this narrative
2 users have commented on this narrative
9 users have liked this narrative
WE
WealthAP
NOVO B logo
WealthAP on Novo Nordisk ·

Novo Nordisk (NVO): Is the "Easy Growth" Story Over?

Fair Value:DKK 407.7719.9% undervalued
69 users have followed this narrative
0 users have commented on this narrative
8 users have liked this narrative
VA
ValueInvestingSubstack
ZTS logo
ValueInvestingSubstack on Zoetis ·

Zoetis down -50% over the past year

Fair Value:US$92.9217.2% undervalued
23 users have followed this narrative
0 users have commented on this narrative
9 users have liked this narrative
CE
CentryResearch
LEU logo
CentryResearch on Centrus Energy ·

Centrus Energy: The Next Nuclear Bottleneck Isn't Reactors. It's Fuel.

Fair Value:US$1907.4% undervalued
24 users have followed this narrative
0 users have commented on this narrative
11 users have liked this narrative

Updated Narratives

BR
Brunhilde_Wagner
CPRT logo
Brunhilde_Wagner on Copart ·

Compounder to Cash Generator in Real Time

Fair Value:US$2710.3% overvalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
WI
WisetoWealth
PYPL logo
WisetoWealth on PayPal Holdings ·

The Underrated Transformation of a Digital Payments Giant

Fair Value:US$90.3137.9% undervalued
6 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
BL
Blagget
TERA logo
Blagget on Terra Balcanica Resources ·

The C$4M Explorer Positioned to Become Europe's First Antimony Mine

Fair Value:CA$0.487.5% undervalued
3 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

CU
MSFT logo
CubanEros on Microsoft ·

A wonderful business at reasonable price.

Fair Value:US$419.917.3% undervalued
85 users have followed this narrative
0 users have commented on this narrative
6 users have liked this narrative
OS
oscargarcia
NVDA logo
oscargarcia on NVIDIA ·

The company that went from selling GPUs to gamers to becoming the AI arms dealer of the 21st century.

Fair Value:US$28029.8% undervalued
193 users have followed this narrative
9 users have commented on this narrative
15 users have liked this narrative
BE
PYPL logo
benjamin_lvieq on PayPal Holdings ·

PayPal: PayPal Doesn't Need to Grow – It Needs to Stop Falling – A Mispriced Cash Machine With a Cannibal Buyback

Fair Value:US$6513.7% undervalued
72 users have followed this narrative
2 users have commented on this narrative
11 users have liked this narrative

Trending Discussion

DE
TDOC logo
derek_3wsdg on Teladoc Health ·

You’ve overlooked the activist investor factor. Travis Cocke’s Voss has announced 5% ownership through a 13G filing. They’ve added to that 5% since, and in doing so, have created a structural trap door for 27.42 Million Shares actively sold short. Chuck will announce lots of positives on July 29 but it’s what Voss announces shortly after that will rock the overextended Teledoc shorts. The Walmart partnership is the tip of the iceberg. The market is missing the sheer regulatory and enterprise friction of modern corporate healthcare. Teladoc isn't a "consumer app"; it is the primary digital infrastructure integrated directly into the legacy backends of Tier-1 insurance companies and fortune 500 employers, covering 105 million+ lives. Teladoc is acting as the digital top-of-funnel engine for the world's largest retailer. If Voss pushes the narrative that Teladoc is effectively the outsourced digital brain of Walmart's entire healthcare footprint, the fair value shifts from a basic health multiple to an enterprise distribution premium. Additionally , we are in a structural gold rush for high-quality, legally compliant, longitudinal medical data to train vertical healthcare AI models. Large technology hyperscalers and pharmaceutical giants cannot simply scrape the internet for this; they need structured clinical inputs. Teladoc sits on one of the largest de-identified virtual medical datasets on earth. From the activist playbook , we’ll see Voss demand the immediate creation of a Data & Diagnostics Licensing Division, transforming a legacy liability into an incredibly high-margin, pure-software data asset that requires zero human clinician hours to scale. Chuck is doing great work and deserves credi5 for the Teledoc turnaround but it will be Travis Cocke who will be responsible for a share price way beyond your $15 valuation.

1
|
0
AN
CSMG3 logo
andre_k1tsg on Companhia de Saneamento de Minas Gerais ·

Gostei

0
|
0